Becton Dickinson & Co (BDX)
227.62
-1.22
(-0.53%)
USD |
NYSE |
Jul 05, 14:50
Becton Dickinson SG&A Expense (TTM): 4.734B for March 31, 2024
SG&A Expense (TTM) Chart
Historical SG&A Expense (TTM) Data
Date | Value |
---|---|
March 31, 2024 | 4.734B |
December 31, 2023 | 4.746B |
September 30, 2023 | 4.72B |
June 30, 2023 | 4.764B |
March 31, 2023 | 4.723B |
December 31, 2022 | 4.71B |
September 30, 2022 | 4.708B |
June 30, 2022 | 4.811B |
March 31, 2022 | 4.862B |
December 31, 2021 | 4.818B |
September 30, 2021 | 4.782B |
June 30, 2021 | 4.556B |
March 31, 2021 | 4.336B |
December 31, 2020 | 4.213B |
September 30, 2020 | 4.185B |
June 30, 2020 | 4.22B |
March 31, 2020 | 4.316B |
December 31, 2019 | 4.38B |
September 30, 2019 | 4.332B |
June 30, 2019 | 4.339B |
March 31, 2019 | 4.349B |
December 31, 2018 | 4.316B |
September 30, 2018 | 4.016B |
June 30, 2018 | 3.673B |
March 31, 2018 | 3.306B |
Date | Value |
---|---|
December 31, 2017 | 2.974B |
September 30, 2017 | 2.91B |
June 30, 2017 | 2.948B |
March 31, 2017 | 2.957B |
December 31, 2016 | 2.965B |
September 30, 2016 | 3.004B |
June 30, 2016 | 2.965B |
March 31, 2016 | 2.988B |
December 31, 2015 | 2.767B |
September 30, 2015 | 2.563B |
June 30, 2015 | 2.367B |
March 31, 2015 | 2.144B |
December 31, 2014 | 2.158B |
September 30, 2014 | 2.145B |
June 30, 2014 | 2.461B |
March 31, 2014 | 2.467B |
December 31, 2013 | 2.457B |
September 30, 2013 | 2.422B |
June 30, 2013 | 2.029B |
March 31, 2013 | 1.964B |
December 31, 2012 | 1.937B |
September 30, 2012 | 1.923B |
June 30, 2012 | 1.919B |
March 31, 2012 | 1.918B |
December 31, 2011 | 1.872B |
SG&A Expense Definition
SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.
SG&A Expense (TTM) Range, Past 5 Years
4.185B
Minimum
Sep 2020
4.862B
Maximum
Mar 2022
4.575B
Average
4.71B
Median
Dec 2022
SG&A Expense (TTM) Benchmarks
Edwards Lifesciences Corp | 1.877B |
AngioDynamics Inc | 145.48M |
Boston Scientific Corp | 5.339B |
Abbott Laboratories | 11.15B |
Merit Medical Systems Inc | 377.96M |